Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data

por Bleecker, Eugene R, Siler, Thomas, Owen, Roger, Kramer, Benjamin
Publicado 2011

Asthma pharmacogenetics and the development of genetic profiles for personalized medicine

por Ortega, Victor E, Meyers, Deborah A, Bleecker, Eugene R
Publicado 2015

Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthma

por Svedsater, Henrik, Jacques, Loretta, Goldfrad, Caroline, Bleecker, Eugene R
Publicado 2014

Asthma and gender impact accumulation of T cell subtypes

por Loza, Matthew J, Foster, Susan, Bleecker, Eugene R, Peters, Stephen P, Penn, Raymond B
Publicado 2010

CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity

por Blaisdell, Carol J, Howard, Timothy D, Stern, Augustus, Bamford, Penelope, Bleecker, Eugene R, Stine, O Colin
Publicado 2004

Effect of β(2)-adrenergic receptor gene (ADRB2) 3′ untranslated region polymorphisms on inhaled corticosteroid/long-acting β(2)-adrenergic agonist response

por Ambrose, Helen J, Lawrance, Rachael M, Cresswell, Carl J, Goldman, Mitchell, Meyers, Deborah A, Bleecker, Eugene R
Publicado 2012

123 Serum IL6 and Soluble IL6R Are Correlated With Lung Function in Non-Hispanic Whites with Asthma

por Hawkins, Gregory, Robinson, Mac, Moore, Wendy, Hastie, Annette, Pascual, Rodolfo, Peters, Stephen P., Meyers, Deborah, Bleecker, Eugene R.
Publicado 2012

Exploring pleiotropy using principal components

por Bensen, Jeannette T, Lange, Leslie A, Langefeld, Carl D, Chang, Bao-Li, Bleecker, Eugene R, Meyers, Deborah A, Xu, Jianfeng
Publicado 2003

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study

por Marks, Michelle, Steele, Chad, Moore, Wendy C, Meyers, Deborah A, Rector, Brian, Ampleford, Elizabeth, Bleecker, Eugene R, Hastie, Annette T
Publicado 2020

Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers

por Sadeghnejad, Alireza, Ohar, Jill A, Zheng, Siqun L, Sterling, David A, Hawkins, Gregory A, Meyers, Deborah A, Bleecker, Eugene R
Publicado 2009

24 Common and Rare Variation in the T Helper 2 Gene Pathway Predicts Allergic Asthma Phenotypes

por Slager, Rebecca, Moore, Wendy, Li, Huashi, Busse, William, Castro, Mario, Erzurum, Serpil, Fitzpatrick, Anne, Wenzel, Sally, Meyers, Deborah, Bleecker, Eugene R.
Publicado 2012

Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma

por FitzGerald, J Mark, Bleecker, Eugene R, Bourdin, Arnaud, Busse, William W, Ferguson, Gary T, Brooks, Laura, Barker, Peter, Martin, Ubaldo J
Publicado 2019

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

por Woodcock, Ashley, Bateman, Eric D, Busse, William W, Lötvall, Jan, Snowise, Neil G, Forth, Richard, Jacques, Loretta, Haumann, Brett, Bleecker, Eugene R
Publicado 2011

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

por Woodcock, Ashley, Bleecker, Eugene R, Busse, William W, Lötvall, Jan, Snowise, Neil G, Frith, Lucy, Jacques, Loretta, Haumann, Brett, Bateman, Eric D
Publicado 2011

Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management

por Bleecker, Eugene R., Menzies-Gow, Andrew N., Price, David B., Bourdin, Arnaud, Sweet, Stephen, Martin, Amber L., Alacqua, Marianna, Tran, Trung N.
Publicado 2020

IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial

por Crim, Courtney, Stone, Sally, Millar, Valerie, Lettis, Sally, Bel, Elisabeth H., Menzies-Gow, Andrew, Chanez, Pascal, Wenzel, Sally, Lugogo, Njira, Bleecker, Eugene R.
Publicado 2022

Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma: A Randomi...

por Woodcock, Ashley, Bleecker, Eugene R., Lötvall, Jan, O’Byrne, Paul M., Bateman, Eric D., Medley, Hilary, Ellsworth, Anna, Jacques, Loretta, Busse, William W.
Publicado 2013

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma

por O’Byrne, Paul M., Bleecker, Eugene R., Bateman, Eric D., Busse, William W., Woodcock, Ashley, Forth, Richard, Toler, William T., Jacques, Loretta, Lötvall, Jan
Publicado 2014

Comparison of vilanterol, a novel long-acting beta(2) agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids

por Lötvall, Jan, Bateman, Eric D, Busse, William W, O’Byrne, Paul M, Woodcock, Ashley, Toler, William T, Jacques, Loretta, Goldfrad, Caroline, Bleecker, Eugene R
Publicado 2014

Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial

por O’Byrne, Paul M, Woodcock, Ashley, Bleecker, Eugene R, Bateman, Eric D, Lötvall, Jan, Forth, Richard, Medley, Hilary, Jacques, Loretta, Busse, William W
Publicado 2014